Who Really Owns Your Skincare Brands

Founded in 2020 by Olamide Olowe and Claudia Teng, two women of color who wanted to create effective, science-backed products for chronic skin conditions that mainstream brands largely ignored. Built a community-driven brand around the idea that skin conditions aren't flaws to be fixed but part of a full life. Raised a $10M Series A in 2022 with backing from notable celebrity and institutional investors. Expanded into Sephora nationally. One of the most promising founder-controlled indie skincare brands in the market — and therefore a natural acquisition target as it matures. Still independently led as of early 2026.

⚠ One of the fastest-growing indie skincare brands; raised $10M Series A in 2022. Focused on chronic skin conditions like eczema, hyperpigmentation, and keratosis pilaris. One of the few Black-founded skincare brands to reach national retail scale.

Emily Weiss launched Glossier in 2014 as a spinoff from her beauty blog 'Into The Gloss.' The brand's 'skin first, makeup second' philosophy and direct-to-consumer model made it a darling of VC investors. Raised $1.8B valuation in 2021. Weiss stepped down as CEO in 2022 amid restructuring and layoffs; she later returned in an executive role. Glossier is VC-backed with investors including Sequoia Capital and Index Ventures — meaning an eventual exit (acquisition or IPO) is built into the ownership structure. The question for fans is which conglomerate eventually absorbs it.

⚠ Emily Weiss stepped down as CEO in 2022, then returned in a leadership role as the company restructured. Glossier raised at a $1.8B valuation in 2021 — the beauty brand to watch. Has faced challenges transitioning from a DTC-first model to wholesale retail.

• Lauder family 38%
• Vanguard Group 8.1%
• BlackRock 6.4%

Founded in 1990 by Leonard Lauder (Estée Lauder's son) as a prestige natural beauty brand — one of the first mass-market brands to lean into botanical ingredients and environmental responsibility. Has always been wholly owned by Estée Lauder Companies. Over the decades, Origins has sat somewhat awkwardly in the portfolio — not as clinical as La Mer, not as trendy as Too Faced. Has undergone multiple repositioning attempts. A brand that has never fully escaped its parent's shadow but has also never been subject to an external acquisition.

⚠ Second largest beauty company in the world. The Lauder family retains effective control through Class B supervoting shares. Has spent decades acquiring prestige and indie beauty brands including Clinique, Bobbi Brown, MAC, Jo Malone, and DECIEM.

• Lauder family (Class B supervoting) 38%
• Vanguard Group 7.9%
• BlackRock 6.3%
• State Street 3.1%

The Ordinary was launched in 2013 as part of DECIEM by Brandon Truaxe. Its radically transparent, clinical-ingredient approach at drugstore prices disrupted the prestige skincare market. Estée Lauder Companies took a minority stake in 2017, then acquired full ownership in 2021 following Truaxe's tragic death. ELC is controlled by the Lauder family through supervoting Class B shares — giving the family ~38% of votes despite lower economic ownership. The Ordinary remains an outlier within ELC's otherwise luxury portfolio.

• Vanguard Group 9.3%
• BlackRock 7.9%
• State Street 4.3%

Founded in 1988 by a group of physicians focused on products for use before and after medical procedures, EltaMD built its reputation in the dermatology and plastic-surgery channel — its UV Clear SPF 46 sunscreen achieving cult status. In December 2017, Colgate-Palmolive acquired EltaMD (alongside PCA Skin) to enter professional skin care. It is still sold mainly through licensed medical providers, but ownership now sits with a large publicly traded consumer-goods company rather than an independent physician-run business.

⚠ Colgate-Palmolive acquired EltaMD (with PCA Skin) in December 2017 to enter professional skin care; the brands sit in its CP Skin Health division alongside Filorga. EltaMD is still distributed mainly through dermatologists and plastic surgeons, but it is owned by a public, Wall Street–traded consumer-goods company — not the independent physician-founded operation it is sometimes assumed to be.

• Vanguard Group 9.1%
• BlackRock 6.8%
• State Street 4.5%

Founded in 1945 by brothers Sidney and Albert Musher, who pioneered colloidal-oatmeal skincare, and acquired by Johnson & Johnson in 1999. Like Neutrogena, Aveeno moved to Kenvue in J&J's 2023 consumer-health spinoff, and J&J fully exited its remaining Kenvue stake in 2024. In November 2025 Kimberly-Clark agreed to buy Kenvue for ~$48.7B (shareholders approved January 2026; regulatory review ongoing) — which, if completed, would place Aveeno under Kimberly-Clark's ownership.

⚠ Kenvue was spun off from Johnson & Johnson in 2023; J&J fully exited its remaining stake in 2024. In November 2025 Kimberly-Clark (Kleenex, Huggies, Kotex) agreed to acquire Kenvue for ~$48.7B; shareholders approved in January 2026 and the deal is in final regulatory review. If it closes, Neutrogena, Aveeno, Band-Aid, Tylenol and Listerine move under Kimberly-Clark.

• Vanguard Group 9.1%
• BlackRock 7.3%
• State Street 4.8%

Founded in 1930 in Los Angeles and acquired by Johnson & Johnson in 1994 for $924M. In 2023, J&J spun its consumer-health brands — Neutrogena, Aveeno, Band-Aid, Tylenol, Listerine — into a new public company, Kenvue (NYSE: KVUE), and fully exited its remaining stake in 2024. In November 2025 Kimberly-Clark agreed to acquire Kenvue for ~$48.7B (shareholders approved January 2026; regulatory review ongoing). If the deal closes, Neutrogena will sit alongside Kleenex and Huggies inside Kimberly-Clark.

⚠ Kenvue was spun off from Johnson & Johnson in 2023; J&J fully exited its remaining stake in 2024. In November 2025 Kimberly-Clark (Kleenex, Huggies, Kotex) agreed to acquire Kenvue for ~$48.7B; shareholders approved in January 2026 and the deal is in final regulatory review. If it closes, Neutrogena, Aveeno, Band-Aid, Tylenol and Listerine move under Kimberly-Clark.

• Maxingvest AG (Herz family) 51%
• Public float 49%

Introduced by Beiersdorf in 1925 as a pharmaceutical-grade healing ointment. For decades it was a niche pharmacy product with a loyal following among burn units, dermatologists, and parents of newborns. Has experienced a dramatic rise in mainstream popularity through dermatologist social media, particularly the trend of 'slugging' (applying a petrolatum-based occlusive as the final step of a skincare routine). Remains part of Beiersdorf's family-controlled portfolio, which has resisted the kind of ownership churn that has affected most of its American competitors.

⚠ German consumer goods company founded in 1882. Controlled by the Herz family through Maxingvest AG. Manufactures NIVEA, Eucerin, Aquaphor, La Prairie, and Hansaplast. Known for long-term product stability and relatively conservative brand management.

• Maxingvest AG (Herz family) 51%
• Public float 49%

Developed in Germany at the turn of the 20th century as a pharmaceutical-grade moisturizer, using a lanolin-water emulsion formula (Eucerit) that became the basis for modern emollient skincare. Has been part of Beiersdorf since the early 1900s. Sold in pharmacies and recommended by dermatologists across Europe and increasingly in the US. Unlike CeraVe or Neutrogena, Eucerin has always been within a family-controlled company — Beiersdorf is majority-owned by the Herz family's Maxingvest AG, which has provided more patient-capital stewardship than a pure public float would. The brand is a rare example of pharmaceutical heritage skincare that hasn't changed hands through acquisition.

⚠ German consumer goods company founded in 1882. Controlled by the Herz family through Maxingvest AG. Manufactures NIVEA, Eucerin, Aquaphor, La Prairie, and Hansaplast. Known for long-term product stability and relatively conservative brand management.

• Bettencourt Meyers family (founding heirs) 33.3%
• Nestlé S.A. 20%
• Free float 46.7%

Founded in 1975 in the spa town of La Roche-Posay, France, drawing on the area's selenium-rich thermal spring water with documented dermatological benefits. Built a strong reputation in European pharmacies for sensitive and reactive skin. Acquired by L'Oréal in 1989 as part of its Active Cosmetics Division push into pharmacy-channel skincare. Has maintained significant dermatological credibility — it is frequently recommended by dermatologists globally — in part because L'Oréal has kept the Active Cosmetics division relatively insulated from its mass-market pressures. The Anthelios sunscreen line in particular is widely regarded as among the best sun protection available globally.

• Bettencourt Meyers family (founding heirs) 33.3%
• Nestlé S.A. 20%
• Free float 46.7%

Founded in 1994 by Dr. Sheldon Pinnell, a pioneer in vitamin C antioxidant research at Duke University. Built around the peer-reviewed science of topical vitamin C stabilization and photoprotection. Sold through licensed medical providers only — a deliberate channel strategy designed to maintain clinical credibility. Acquired by L'Oréal in 2005. L'Oréal has largely preserved the clinical distribution model; SkinCeuticals still sells primarily through dermatologists and plastic surgeons. The premium pricing ($166+ for a vitamin C serum) persists. A rare case where acquisition by a conglomerate hasn't obviously degraded the brand's medical integrity.

• Bettencourt Meyers family (founding heirs) 33.3%
• Nestlé S.A. 20%
• Free float 46.7%

Founded in 2005 by a team including dermatologist Dr. Michael Gold, based on research into ceramides (lipids that maintain the skin barrier). Became the #1 dermatologist-recommended skincare brand. Acquired by L'Oréal in 2017 for ~$1.3B. L'Oréal, the world's largest beauty company, is controlled by the Bettencourt Meyers family (founding heirs) and Nestlé. CeraVe has maintained its clinical credibility post-acquisition, though it has significantly expanded its product range and price points.

• Japan Trustee Services Bank 10.1%
• Vanguard Group 3.2%
• BlackRock 2.8%

Founded in 2012 by Tiffany Masterson in Houston, TX, built on the concept of eliminating 'suspicious 6' ingredients (essential oils, drying alcohols, silicones, chemical screens, fragrances/dyes, SLS). Became a cult brand on Reddit and social media. Acquired by Shiseido for $845M in 2019. Shiseido is a 150-year-old Japanese beauty conglomerate. Masterson exited the company in 2023. The brand's original philosophy is now executed without its founder.

• Vanguard Group 4.1%
• BlackRock 3.8%
• Norges Bank 2.9%
• Flossbach von Storch 2.2%

Founded in 1995 by Paula Begoun, the self-described 'Cosmetics Cop' who had built a following through books like 'Don't Go to the Cosmetics Counter Without Me' — exposing misleading marketing claims in the beauty industry. Built the brand on the principle that skincare should be evidence-based and fragrance-free. Acquired by Unilever in 2021. Begoun departed following the acquisition. Long-time customers have noted changes in formulations and packaging decisions since acquisition, and the brand's founding ethos of skepticism toward Big Beauty is now somewhat awkward given its ownership by one of Big Beauty's largest players.